Projection: Implantable drug delivery market to reach $21.1B by 2018

Transparency Market Research predicts that the worldwide implantable drug delivery market will reach $21.1 billion by 2018. The market stood at $11.6 billion in 2011. Drivers of growth include cardiovascular diseases, diabetic retinopathy, colorectal cancer, chronic pain conditions, aging populations and unwanted pregnancies. In terms of specific devices, bioresorbable stents will propel the market's growth. And the Asia-Pacific region will see increased demand. Release

Suggested Articles

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.

Researchers at Johns Hopkins have changed the structure of a new cancer drug to allow it to more easily pass the blood-brain barrier, giving it access to…

Medtronic’s world-first FDA-approved hybrid closed-loop insulin delivery system might soon face competition, as T1D Exchange has pledged to invest in the…